arBtrage CAPITALIZING MARKETS — checking… Sign in Sign up
Calendar /

MacroGenics, Inc.

MGNX Health Care Biotechnology: Pharmaceutical Preparations
$2.25
▼ -37.3% Today
as of Oct 23, 16:50 ET
Last 30 days -46.43% Sep 14 → Oct 23
$2.09 $2.66 $3.22 $3.79 $4.36 Sep 14 Sep 22 Sep 30 Oct 07 Oct 15 Oct 23
Open
$3.55
High
$3.56
Low
$2.13
Volume
$4M
Avg Vol
$1M
Mkt Cap
$229M
P/E (TTM)
—
Beta
—
52w High
$5.08
52w Low
$1.29
Div Yield
—
Shares Out
$64M

Recent Press Releases & News last 60 days · 5 items

Oct 23 · 13:15 PR GlobeNewswire
MacroGenics Announces Positive Interim Phase 1 Results for MGC026 and Highlights Plans to Initiate Front-Line Combination Study in SCCHN
Oct 15 · 21:00 MT Newswires
MacroGenics Says First Patient Dosed in Phase 1 Study of MGC030 for Advanced Solid Tumors
Oct 15 · 20:05 PR GlobeNewswire
MacroGenics Announces First Patient Dosed in Phase 1 Study of MGC030 in Patients with Advanced Solid Tumors
▸ Show all 5 press releases & news Free account →

MGNX earnings at a glance

The options market is pricing a move of about ±26.8% after the report, a range of roughly $1.65 to $2.85 from today's $2.25. Over its last 2 reports the stock rose the next day 0 times and fell 2, moving ±2.6% on average; after the most recent report on May 13, 2026 it moved -2.0%. That means options currently expect more movement than MGNX has typically delivered. MGNX beat the consensus EPS estimate in 2 of its last 4 reported quarters. Implied volatility is currently 227%. The share price of $2.25 sits in the middle of its 52-week range.

More Health Care stocks · All stocks · Earnings calendar

Overview

52-week range
$1.29
$5.08
25% of range
Avg surprise (last 4)
+37.8%
Avg reaction (last 2)
-2.6%
0% positive
Latest IV / EM
227%
EM ±26.8% · $4 · Oct 16

Earnings trends

EPS — actual vs estimate Actual Estimate
$-0.89$-0.44$0.02$0.47$0.92 Actual $-0.61Actual $0.92Actual $0.28Actual $-0.84Actual $-0.89Actual $0.90Actual $-0.65Est $-0.61Actual $-0.57Est $-0.59Actual $0.27Est $-0.48Actual $-0.58Est $-0.57Actual $0.31 MarJunSepMarJunSepMar/2025Jun/2025Sep/2025Mar/2026Jun
Revenue vs Net Income Revenue Net income
$-41M$-2M$38M$77M$116M Sep 24Mar 25Jun 25Sep 25Mar 26Jun 26

Earnings history

DatePeriodActual EPSEstSurpriseYoY %ΔDay reactSource
Tue Jun 30, 2026Jun 2026 $0.31 — — — — financials
Wed May 13, 2026Mar/2026 $-0.58 $-0.57 -1.8% +10.8% -2.0% earnings
Wed Nov 12, 2025Sep/2025 $0.27 $-0.48 +156.2% — — earnings
Thu Aug 14, 2025Jun/2025 $-0.57 $-0.59 +3.4% — — earnings
Tue May 13, 2025Mar/2025 $-0.65 $-0.61 -6.6% — -3.1% earnings
Mon Sep 30, 2024Sep 2024 $0.90 — — — — financials
Sun Jun 30, 2024Jun 2024 $-0.89 — — — — financials
Sun Mar 31, 2024Mar 2024 $-0.84 — — — — financials
Sat Sep 30, 2023Sep 2023 $0.28 — — — — financials
Fri Jun 30, 2023Jun 2023 $0.92 — — — — financials
Fri Mar 31, 2023Mar 2023 $-0.61 — — — — financials

Financials

Income statement (quarterly)

MetricJun 2026Mar 2026Dec 2025Sep 2025Jun 2025Mar 2025Dec 2024Sep 2024
Revenue$33M$21M—$73M$7M$13M—$111M
Cost of revenue———$0$0$0—$168,000
Gross profit————————
Operating income$-14M$-33M—$19M$-43M$-43M—$54M
Net income$20M$-37M—$17M$-36M$-41M—$56M
EPS (diluted)$0.31$-0.58—$0.27$-0.57$-0.65—$0.90

Balance sheet (quarterly)

MetricJun 2026Mar 2026Dec 2025Sep 2025Jun 2025Mar 2025Dec 2024Sep 2024
Cash & equivalents$114M$67M$57M$80M$131M$146M$183M$180M
Inventory—$9M$8M$9M$9M$9M$0$3M
Total current assets$322M$183M$220M$232M$205M$182M$217M$222M
Total assets$345M$218M$257M$271M$245M$225M$262M$264M
Long-term debt————————
Total liabilities$303M$197M$201M$204M$199M$145M$146M$144M
Total equity$43M$21M$56M$67M$47M$79M$116M$120M

Implied volatility — last 90 days

47%137%226%316%405% Jun 07 — IV 125% · EM ±17.3%Jun 08 — IV 205% · EM ±27.1%Jun 09 — IV 163% · EM ±20.5%Jun 10 — IV 241% · EM ±28.4%Jun 15 — IV 151% · EM ±10.9%Jun 16 — IV 349% · EM ±20.6%Jun 19 — IV 99% · EM ±21.8%Jun 22 — IV 122% · EM ±25.5%Jun 23 — IV 99% · EM ±20.3%Jun 24 — IV 91% · EM ±18.3%Jun 25 — IV 112% · EM ±22.0%Jun 26 — IV 87% · EM ±16.6%Jun 29 — IV 81% · EM ±14.4%Jun 30 — IV 138% · EM ±23.8%Jul 01 — IV 117% · EM ±19.5%Jul 02 — IV 98% · EM ±15.9%Jul 03 — IV 102% · EM ±15.9%Jul 13 — IV 226% · EM ±18.9%Jul 14 — IV 201% · EM ±14.6%Jul 15 — IV 333% · EM ±19.7%Jul 16 — IV 378% · EM ±15.8%Jul 20 — IV 127% · EM ±30.1%Jul 21 — IV 175% · EM ±40.7%Jul 22 — IV 109% · EM ±25.0%Jul 23 — IV 142% · EM ±32.0%Jul 24 — IV 113% · EM ±25.0%Jul 27 — IV 105% · EM ±21.9%Jul 30 — IV 209% · EM ±41.0%Jul 31 — IV 135% · EM ±25.7%Aug 03 — IV 96% · EM ±17.0%Aug 04 — IV 97% · EM ±16.7%Aug 05 — IV 100% · EM ±16.7%Aug 06 — IV 108% · EM ±17.5%Aug 07 — IV 95% · EM ±14.9%Aug 10 — IV 203% · EM ±28.2%Aug 11 — IV 288% · EM ±38.1%Aug 12 — IV 134% · EM ±16.8%Aug 13 — IV 150% · EM ±17.8%Aug 14 — IV 118% · EM ±13.0%Aug 18 — IV 118% · EM ±8.6%Aug 19 — IV 310% · EM ±18.3%Aug 20 — IV 382% · EM ±16.0%Aug 24 — IV 80% · EM ±16.8%Aug 25 — IV 100% · EM ±20.4%Aug 26 — IV 117% · EM ±23.5%Aug 27 — IV 69% · EM ±13.5%Aug 28 — IV 88% · EM ±16.9%Sep 04 — IV 168% · EM ±26.2%Sep 07 — IV 189% · EM ±26.1%Sep 08 — IV 202% · EM ±26.6%Sep 09 — IV 165% · EM ±20.7%Sep 10 — IV 107% · EM ±12.6%Sep 11 — IV 249% · EM ±27.5%Sep 14 — IV 299% · EM ±25.0%Sep 15 — IV 291% · EM ±21.0%Sep 16 — IV 228% · EM ±13.5%Sep 17 — IV 406% · EM ±16.9%Sep 21 — IV 61% · EM ±12.7%Sep 22 — IV 47% · EM ±9.7%Sep 23 — IV 92% · EM ±18.4%Sep 24 — IV 101% · EM ±19.7%Sep 25 — IV 105% · EM ±20.1%Sep 28 — IV 70% · EM ±12.3%Sep 29 — IV 69% · EM ±11.9%Sep 30 — IV 85% · EM ±14.2%Oct 01 — IV 155% · EM ±25.0%Oct 02 — IV 161% · EM ±25.1%Oct 06 — IV 177% · EM ±23.4%Oct 07 — IV 214% · EM ±26.8%Oct 08 — IV 227% · EM ±26.8%

Sector peers

PRQR
ProQR Therapeutics N.V.
$230M $1.29-5.8%
SIGA
SIGA Technologies Inc.
$234M $3.120.0%
KROS
Keros Therapeutics, Inc.
$222M $11.28+0.9%
NATR
Nature's Sunshine Products, Inc.
$222M $12.15-0.9%
SLGL
Sol-Gel Technologies Ltd.
$238M $69.45+5.7%
SION
Sionna Therapeutics, Inc.
$218M $3.60-7.0%

MGNX earnings FAQ

What is MGNX's expected move for earnings?

Options currently price a move of about ±26.8%, or $0.60 per share either way from $2.25.

How does MGNX stock usually react to earnings?

Across the last 2 reports the average next-day move was ±2.6%, up 0 times and down 2 times.

What is MGNX's implied volatility?

MGNX's at-the-money implied volatility is about 227% based on the latest options snapshot.

View on Nasdaq ↗
🔒 Preview mode. Create a free account to unlock the full earnings calendar, all panels, heatmaps, options flow, and screener.
Sign up free → Sign in